Charlotte Choi

Cell Biologist @Catenabio

Berkeley, CA, US

Characterize the MOA of CatenaBio multi-payload conjugates in 15 different cancer cell lines (breast, gastric, liver, and lung) to define therapeutic efficacy and differentiate from current mono-payload ADCs in the clinic- Performed cytotoxicity assays in cancer cell lines for the selection and prioritization of PDX/CDX models- Established antigen profiling SOP using multi-parameter flow cytometry to quantify antigen expression levels in cancer cells, ensuring cross-functional reproducibility.

The Johns Hopkins University

Doctor of Philosophy (Ph.D.), Cell/Cellular and Molecular Biology

Boston University

Bachelor of Arts (B.A.), Biology